195 related articles for article (PubMed ID: 26967642)
61. [Association of insulin, insulin-like growth factor and insulin-like growth factor binding proteins with the risk of colorectal cancer].
Jiang B; Liu DB; Zhang X; DU LL; Han CZ
Zhonghua Wei Chang Wai Ke Za Zhi; 2009 May; 12(3):264-8. PubMed ID: 19434535
[TBL] [Abstract][Full Text] [Related]
62. Relationship of leptin, growth hormone, and insulin-like growth factor levels with body mass index and disease severity in patients with fibromyalgia syndrome.
Koca TT; Berk E; Seyithanoğlu M; Koçyiğit BF; Demirel A
Acta Neurol Belg; 2020 Jun; 120(3):595-599. PubMed ID: 30547374
[TBL] [Abstract][Full Text] [Related]
63. Association between serum insulin-like growth factor 1 and osteoporosis risk in Parkinson's disease: a cross-sectional study.
Geng C; Chen C
Neurol Sci; 2024 Jun; ():. PubMed ID: 38898339
[TBL] [Abstract][Full Text] [Related]
64. Creation of a gene expression classifier for predicting Parkinson's disease rate of progression.
Rabey JM; Yarden J; Dotan N; Mechlovich D; Riederer P; Youdim MBH
J Neural Transm (Vienna); 2020 May; 127(5):755-762. PubMed ID: 32385576
[TBL] [Abstract][Full Text] [Related]
65. Elevated serum levels of free insulin-like growth factor I in polycystic ovary syndrome.
Thierry van Dessel HJ; Lee PD; Faessen G; Fauser BC; Giudice LC
J Clin Endocrinol Metab; 1999 Sep; 84(9):3030-5. PubMed ID: 10487660
[TBL] [Abstract][Full Text] [Related]
66. High-sensitivity C-reactive protein and high mobility group box-1 levels in Parkinson's disease.
Baran A; Bulut M; Kaya MC; Demirpençe Ö; Sevim B; Akıl E; Varol S
Neurol Sci; 2019 Jan; 40(1):167-173. PubMed ID: 30353300
[TBL] [Abstract][Full Text] [Related]
67. Moderate energy restriction-induced weight loss affects circulating IGF levels independent of dietary composition.
Belobrajdic DP; Frystyk J; Jeyaratnaganthan N; Espelund U; Flyvbjerg A; Clifton PM; Noakes M
Eur J Endocrinol; 2010 Jun; 162(6):1075-82. PubMed ID: 20212016
[TBL] [Abstract][Full Text] [Related]
68. Circulating IGF-1 Independently Predicts Blood Pressure in Children With Higher Calcium-Phosphorus Product Levels.
Xargay-Torrent S; Dorado-Ceballos E; Benavides-Boixader A; Lizárraga-Mollinedo E; Mas-Parés B; Montesinos-Costa M; De Zegher F; Ibáñez L; Bassols J; López-Bermejo A
J Clin Endocrinol Metab; 2020 Jan; 105(1):. PubMed ID: 31633765
[TBL] [Abstract][Full Text] [Related]
69. Effects of rasagiline combined with levodopa and benserazide hydrochloride on motor function and homocysteine and IGF-1 levels in elderly patients with Parkinson's disease.
Yang Y; Gao F; Gao L; Miao J
BMC Neurol; 2023 Oct; 23(1):360. PubMed ID: 37803329
[TBL] [Abstract][Full Text] [Related]
70. A longitudinal study on α-synuclein in plasma neuronal exosomes as a biomarker for Parkinson's disease development and progression.
Niu M; Li Y; Li G; Zhou L; Luo N; Yao M; Kang W; Liu J
Eur J Neurol; 2020 Jun; 27(6):967-974. PubMed ID: 32150777
[TBL] [Abstract][Full Text] [Related]
71. Motor symptoms in Parkinson's disease are related to the interplay between cortical curvature and thickness.
Almgren H; Hanganu A; Camacho M; Kibreab M; Camicioli R; Ismail Z; Forkert ND; Monchi O
Neuroimage Clin; 2023; 37():103300. PubMed ID: 36580712
[TBL] [Abstract][Full Text] [Related]
72. Low Serum Insulinlike Growth Factor II Levels Correlate with High BMI in American Indian Adults.
Muller YL; Hanson RL; Mahkee D; Piaggi P; Kobes S; Hsueh WC; Knowler WC; Bogardus C; Baier LJ
Obesity (Silver Spring); 2020 Mar; 28(3):676-682. PubMed ID: 32030914
[TBL] [Abstract][Full Text] [Related]
73. Proteomic Profiling of Exosomal Proteins for Blood-based Biomarkers in Parkinson's Disease.
Kitamura Y; Kojima M; Kurosawa T; Sasaki R; Ichihara S; Hiraku Y; Tomimoto H; Murata M; Oikawa S
Neuroscience; 2018 Nov; 392():121-128. PubMed ID: 30266682
[TBL] [Abstract][Full Text] [Related]
74. Senescence and Inflammatory Markers for Predicting Clinical Progression in Parkinson's Disease: The ICICLE-PD Study.
Martin-Ruiz C; Williams-Gray CH; Yarnall AJ; Boucher JJ; Lawson RA; Wijeyekoon RS; Barker RA; Kolenda C; Parker C; Burn DJ; Von Zglinicki T; Saretzki G
J Parkinsons Dis; 2020; 10(1):193-206. PubMed ID: 31868677
[TBL] [Abstract][Full Text] [Related]
75. Low IGF-1 levels are associated with cardiovascular risk factors in haemodialysis patients.
Abdulle AM; Gillett MP; Abouchacra S; Sabri SM; Rukhaimi MA; Obineche EN; Singh J
Mol Cell Biochem; 2007 Aug; 302(1-2):195-201. PubMed ID: 17387582
[TBL] [Abstract][Full Text] [Related]
76. Substantia Nigra Neuromelanin as an Imaging Biomarker of Disease Progression in Parkinson's Disease.
Fabbri M; Reimão S; Carvalho M; Nunes RG; Abreu D; Guedes LC; Bouça R; Lobo PP; Godinho C; Coelho M; Gonçalves NC; Rosa MM; Antonini A; Ferreira JJ
J Parkinsons Dis; 2017; 7(3):491-501. PubMed ID: 28671143
[TBL] [Abstract][Full Text] [Related]
77. Relationships between IGF-I and age, gender, body mass, fat distribution, metabolic and hormonal variables in obese patients.
Maccario M; Ramunni J; Oleandri SE; Procopio M; Grottoli S; Rossetto R; Savio P; Aimaretti G; Camanni F; Ghigo E
Int J Obes Relat Metab Disord; 1999 Jun; 23(6):612-8. PubMed ID: 10411234
[TBL] [Abstract][Full Text] [Related]
78. Evolution of Alzheimer's Disease Cerebrospinal Fluid Biomarkers in Early Parkinson's Disease.
Irwin DJ; Fedler J; Coffey CS; Caspell-Garcia C; Kang JH; Simuni T; Foroud T; Toga AW; Tanner CM; Kieburtz K; Chahine LM; Reimer A; Hutten S; Weintraub D; Mollenhauer B; Galasko DR; Siderowf A; Marek K; Trojanowski JQ; Shaw LM;
Ann Neurol; 2020 Sep; 88(3):574-587. PubMed ID: 32542885
[TBL] [Abstract][Full Text] [Related]
79. Serum but not cerebrospinal fluid levels of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 (IGFBP-3) are increased in Alzheimer's disease.
Johansson P; Åberg D; Johansson JO; Mattsson N; Hansson O; Ahrén B; Isgaard J; Åberg ND; Blennow K; Zetterberg H; Wallin A; Svensson J
Psychoneuroendocrinology; 2013 Sep; 38(9):1729-37. PubMed ID: 23473966
[TBL] [Abstract][Full Text] [Related]
80. Insulin-like growth factor-I and insulin-like growth factor binding protein-1 are related to cardiovascular disease biomarkers in obese adolescents.
Katz LE; Gralewski KA; Abrams P; Brar PC; Gallagher PR; Lipman TH; Brooks LJ; Koren D
Pediatr Diabetes; 2016 Mar; 17(2):77-86. PubMed ID: 25491378
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
